Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Evaluation of the Susceptibility of Enterobacteriaceae and Pseudomonas Aeruginosa to Ceftolozane/Tazobactam Combination

NCT03963297 is registered in ClinicalTrials.gov with Fondation Hôpital Saint-Joseph as lead sponsor.

NCT NCT03963297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03963297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Evaluation of the Susceptibility of Enterobacteriaceae and Pseudomonas Aeruginosa to Ceftolozane/Tazobactam Combination
Lead sponsor
Fondation Hôpital Saint-Joseph
Phase
Observational
Overall status
Completed
Start date
March 1, 2019
Completion date
December 30, 2022
Enrollment
747 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic resistant strain